¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À¯Àüü ½ÃÄö½Ì ½ÃÀå : Á¦Ç°º°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º° - ºÐ¼®°ú ¿¹Ãø(2024-2033³â)
Asia-Pacific Genome Sequencing Market: Focus on Product, End User, and Country - Analysis and Forecast, 2024-2033
»óǰÄÚµå : 1643948
¸®¼­Ä¡»ç : BIS Research Inc.
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,702,000
PDF and Excel (1-3 User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 3¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,900 £Ü 7,089,000
PDF and Excel (Global License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¾Æ½Ã¾ÆÅÂÆò¾ç À¯Àüü ½ÃÄö½Ì ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 13¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù.

ÀÌ ½ÃÀåÀº 2024³âºÎÅÍ 2033³â¿¡ °ÉÃÄ 18.44%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2033³â¿¡´Â 59¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. °úÇÐÀÚµéÀº À¯Àüü ½ÃÄö½ÌÀ¸·Î ¾Ë·ÁÁø °úÁ¤ÀÎ DNAÀÇ Àüü ¿°±â ¼­¿­À» °áÁ¤ÇÔÀ¸·Î½á À¯±âüÀÇ Àüü À¯ÀüÀÚ ±¸¼ºÀ» ÇØµ¶ÇÒ ¼ö ÀÖ½À´Ï´Ù. À¯ÀüÀû µ¹¿¬º¯À̸¦ ¹ß°ßÇÏ°í ±×°ÍÀÌ °Ç°­°ú Áúº´¿¡ ¹ÌÄ¥ ¼ö ÀÖ´Â ¿µÇâÀ» ÀÌÇØÇÏ·Á¸é ÀÌ ÀýÂ÷°¡ ÇÊ¿äÇÕ´Ï´Ù. Â÷¼¼´ë ½ÃÄö½Ì(NGS) ±â¼úÀ» ÀÌ¿ëÇÑ Ãâ»ý Àü ¹× ½Å»ý¾Æ ½ºÅ©¸®´× ÇÁ·Î±×·¥¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, À¯ÀüÀÚ °Ë»ç äÅà Ȯ´ë ¹× ½ÃÄö½Ì ºñ¿ë °¨¼Ò·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À¯Àüü ½ÃÄö½Ì ½ÃÀåÀº ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀÌ È®´ëµÇ°í ÀÖ´Â °ÍÀº º¹ÀâÇÑ À¯ÀüÀÚ µ¥ÀÌÅÍÀÇ º¸´Ù Á¤È®ÇÏ°í »ó¼¼ÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÏ´Â ±ä ¸®µå ½ÃÄö½ÌÀÇ ¿ëµµ°¡ È®´ëµÇ°í ÀÖ´Â °á°úÀÔ´Ï´Ù. ¶ÇÇÑ ¾Æ½Ã¾ÆÅÂÆò¾ç Àü¿ªÀÇ Á¤ºÎ ÇÁ·Î±×·¥ ¹× ÅõÀÚ´Â À¯Àüü ½ÃÄö½Ì ±â¼úÀÇ µµÀÔÀ» °¡¼ÓÈ­Çϰí ÀÇ·á ¹× °úÇÐ ¾ÖÇø®ÄÉÀ̼ǿ¡ ´ëÇÑ ¾×¼¼½º¸¦ Çâ»ó½Ãŵ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
¿¹Ãø ±â°£ 2024-2033³â
2024³â Æò°¡ 13¾ï ´Þ·¯
2033³â ¿¹Ãø 59¾ï 6,000¸¸ ´Þ·¯
CAGR 18.44%

ÀÌ Áö¿ªÀÌ ÇコÄɾîÀÇ Áøº¸¿Í Á¤¹ÐÀǷḦ ¿ì¼±½ÃÇϰí ÀÖ´Â °¡¿îµ¥, À¯Àüü ½ÃÄö½ÌÀº Áø´Ü, °³ÀÎÈ­ Ä¡·á, Áúº´ ¿¹¹æÀ» °­È­Çϱâ À§ÇÑ Áß¿äÇÑ Åø·Î¼­ ´ëµÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº Çõ½ÅÀ» ÃËÁøÇÏ°í ¼ÒºñÀÚÀÇ Á¢±ÙÀ» È®´ëÇÏ°í ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À¯Àüü ½ÃÄö½Ì ½ÃÀåÀÇ ¹Ì·¡¸¦ Çü¼ºÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À¯Àüü ½ÃÄö½Ì ½ÃÀåÀº ½ÃÄö½Ì ±â¼úÀÇ Çâ»ó, °¡°Ý Ç϶ô, ¿¬±¸ ¹× ÇコÄÉ¾î »ê¾÷¿¡¼­ À¯ÀüÀÚ °Ë»ç ¿ä±¸ Áõ°¡·Î ±Þ¼ÓÈ÷ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Precision MedicineÀÇ Áß¿äÇÑ ±¸¼º¿ä¼ÒÀÎ À¯Àüü ½ÃÄö½ÌÀº À¯±âüÀÇ Àüü DNA ¼­¿­À» ¹àÇô³»°í ´õ ³ªÀº Áúº´ ¿¹¹æ, °³º° Ä¡·á °èȹ, Áø´Ü °­È­¸¦ ÃËÁøÇÕ´Ï´Ù.

½ÃÀå È®´ëÀÇ ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â ¾Ï Áø´Ü, Èñ±ÍÁúȯ ½Äº°, Ãâ»ý Àü ½Å»ý¾Æ ½ºÅ©¸®´×¿¡¼­ Â÷¼¼´ë ½ÃÄö½Ì(NGS)ÀÇ »ç¿ë È®´ëÀÔ´Ï´Ù. ¶ÇÇÑ º¹ÀâÇÑ À¯ÀüÀÚ µ¥ÀÌÅÍ¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀÌÇØ¸¦ Á¦°øÇÏ´Â ±ä ¸®µå ½ÃÄö½Ì ±â¼úµµÀÌ ºÐ¾ß¿¡¼­ ³Î¸® º¸±ÞµÇ°í ÀÖ½À´Ï´Ù.

½ÃÄö½Ì ±â¼ú äÅÃÀ» ¼­µÎ¸£±â À§ÇØ ¾Æ½Ã¾ÆÅÂÆò¾ç Á¤ºÎ´Â À¯Àüü ¿¬±¸¿Í °Ç°­ °ü¸® ÀÎÇÁ¶ó¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇÁ·Î±×·¥Àº ±³À°±â°ü°ú ºñ°ø°³ ȸ»ç°£ÀÇ Á¦ÈÞ¿Í ÇÔ²² Á¢±Ù¼º°ú Çõ½ÅÀ» °­È­Çϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À¯Àüü ½ÃÄö½Ì ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² Á¦Ç°º°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

Á¦1Àå À¯Àüü ½ÃÄö½Ì ½ÃÀå : ¾÷°è ºÐ¼®

Á¦2Àå À¯Àüü ½ÃÄö½Ì ½ÃÀå : ½ÃÀå ¿ªÇÐ

Á¦3Àå À¯Àüü ½ÃÄö½Ì ½ÃÀå : Àå·¡ÀÇ Àü¸Á

Á¦4Àå À¯Àüü ½ÃÄö½Ì ½ÃÀå(Áö¿ªº°)

Á¦5Àå À¯Àüü ½ÃÄö½Ì ½ÃÀå - °æÀï º¥Ä¡¸¶Å· ¹× ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦6Àå Á¶»ç ¹æ¹ý

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Introduction to Asia-Pacific Genome Sequencing Market

The Asia-Pacific genome sequencing market was valued at $1.30 billion in 2024 and is expected to reach $5.96 billion by 2033, growing at a CAGR of 18.44% between 2024 and 2033. Scientists can decipher an organism's entire genetic composition by determining its entire DNA sequence, a process known as genome sequencing. Finding genetic variations and comprehending their possible effects on health and illness require this procedure. Due to rising demand for prenatal and neonatal screening programs using next-generation sequencing (NGS) technologies, growing adoption of genetic testing, and falling sequencing costs, the genome sequencing market in Asia-Pacific is growing quickly.

The market is growing as a result of long-read sequencing's growing applications, which offer more precise and in-depth insights into complicated genetic data. Furthermore, government programs and investments throughout Asia-Pacific are speeding up the adoption of genome sequencing technologies and improving accessibility for medical and scientific applications.

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$1.30 Billion
2033 Forecast$5.96 Billion
CAGR18.44%

As the area continues to prioritize healthcare advancements, and precision medicine, genome sequencing is emerging as a vital tool for enhancing diagnostics, personalized treatments, and disease prevention. These factors are expected to drive innovation and expand consumer access, shaping the future of the genome sequencing market in APAC.

Market Introduction

The market for APAC genome sequencing is expanding quickly due to improvements in sequencing technology, falling prices, and an increase in the need for genetic testing in the research and healthcare industries. A key component of precision medicine, genome sequencing reveals an organism's entire DNA sequence, facilitating better disease prevention, individualized treatment plans, and enhanced diagnostics.

One of the main factors propelling market expansion is the growing use of next-generation sequencing (NGS) in cancer diagnostics, rare disease identification, and prenatal and neonatal screening. Technologies for long-read sequencing, which offer in-depth understanding of intricate genetic data, are also becoming more popular in the area.

To hasten the adoption of sequencing technologies, governments throughout Asia-Pacific are making significant investments in genomic research and healthcare infrastructure. These programs, along with partnerships among educational institutions and private companies, are enhancing accessibility and innovation.

As the region prioritizes advancements in healthcare and precision medicine, the APAC genome sequencing market is poised for sustained growth, transforming medical research and improving patient outcomes.

Market Segmentation

Segmentation 1: by Product

Segmentation 2: by End User

Segmentation 3: by Region

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific genome sequencing market has been segmented based on various categories, such as by product, end user, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Partnerships, alliances, funding, new offerings, and business expansions together accounted for the maximum number of key developments of the total developments in the Asia-Pacific genome sequencing market.

Competitive Strategy: The Asia-Pacific genome sequencing market is a highly fragmented market, with many public and few private companies. Key players in the Asia-Pacific genome sequencing market analyzed and profiled in the study involve established players that offer various kinds of products.

Table of Contents

Executive Summary

Scope and Definition

1 Genome Sequencing Market: Industry Analysis

2 Genome Sequencing Market: Market Dynamics

3 Genome Sequencing Market: Future Outlook

4 Genome sequencing market (By Region)

5 Genome sequencing market - Competitive Benchmarking and Company Profiles

6 Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â